Laboratorios Farma | ROVI - Creditori Commerciali

Prezzo Delle Azioni
59.43
Cambio Giornaliero
-0.43 -0.71%
Mensile
-29.76%
Annuale
13.41%
Q2 Previsione
61.25




Creditori Commerciali Cambiamento Data
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Alaunos Therapeutics USD 613K 230K 2025-12
Almirall EUR 258.05M 58.66M 2025-12
Avita Medical AUD 8.96M 1.69M 2025-12
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
IQVIA Holdings USD 3.64B 112M 2026-03
Laboratorios Farma EUR 107.59M 341K 2023-12
Moderna USD 161M 156M 2026-03
Organon & Co USD 983M 31M 2026-03
Pharma Mar EUR 43.83M 10.51M 2026-03
Revvity USD 169.68M 15.78M 2026-03
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Viatris USD 1.2B 93.9M 2026-03
Xeris Pharmaceuticals USD 11.47M 8.39M 2026-03